| A phase I first-in-human study of enoticumab (REGN421), a fully human delta-like ligand 4 (Dll4) monoclonal antibody in patients with advanced solid tumors EG Chiorean, P LoRusso, RM Strother, JR Diamond, A Younger, ... Clinical Cancer Research 21 (12), 2695-2703, 2015 | 158 | 2015 |
| In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies SS Farag, S Srivastava, S Messina-Graham, J Schwartz, MJ Robertson, ... Stem cells and development 22 (7), 1007-1015, 2013 | 138 | 2013 |
| Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions JD Duke, X Han, Z Wang, A Subhadarshini, SD Karnik, X Li, SD Hall, ... Public Library of Science 8 (8), e1002614, 2012 | 136 | 2012 |
| Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya K Khozaim, E Orang’o, A Christoffersen-Deb, P Itsura, J Oguda, H Muliro, ... International Journal of Gynecology & Obstetrics 124 (1), 12-18, 2014 | 94 | 2014 |
| An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer MS Gordon, F Robert, D Matei, DS Mendelson, JW Goldman, ... Clinical cancer research 20 (23), 5918-5926, 2014 | 88 | 2014 |
| Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice EJ Campbell, MCM Vissers, C Wohlrab, KO Hicks, RM Strother, ... Free Radical Biology and Medicine 99, 451-462, 2016 | 77 | 2016 |
| Measuring the glomerular filtration rate in obese individuals without overt kidney disease AN Friedman, M Strother, SK Quinney, S Hall, SM Perkins, EJ Brizendine, ... Nephron Clinical Practice 116 (3), c224-c234, 2010 | 58 | 2010 |
| AMPATH-Oncology: A model for comprehensive cancer care in sub-Saharan Africa RM Strother, FC Asirwa, NB Busakhala, E Njiru, E Orang’o, F Njuguna, ... Journal of Cancer Policy 1 (3-4), e42-e48, 2013 | 53 | 2013 |
| Epidemiology of diagnosed childhood cancer in Western Kenya S Mostert, F Njuguna, L Kemps, M Strother, L Aluoch, G Buziba, ... Archives of disease in childhood 97 (6), 508-512, 2012 | 52 | 2012 |
| Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations PJ Buffery, RM Strother The New Zealand Medical Journal (Online) 128 (1416), 66, 2015 | 50 | 2015 |
| Assessment of the face validity of two pain scales in Kenya: a validation study using cognitive interviewing KTL Huang, C Owino, RC Vreeman, M Hagembe, F Njuguna, RM Strother, ... BMC palliative care 11, 1-9, 2012 | 50 | 2012 |
| Influence of health‐insurance access and hospital retention policies on childhood cancer treatment in Kenya S Mostert, F Njuguna, PM Van de Ven, G Olbara, L Kemps, J Musimbi, ... Pediatric blood & cancer 61 (5), 913-918, 2014 | 48 | 2014 |
| Prevalence and correlates of pain and pain treatment in a western Kenya referral hospital KTL Huang, C Owino, GP Gramelspacher, PO Monahan, R Tabbey, ... Journal of palliative medicine 16 (10), 1260-1267, 2013 | 43 | 2013 |
| The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study A Landers, H Brown, M Strother Palliative Care: Research and Treatment 12, 1178224218825270, 2019 | 40 | 2019 |
| Development, validation and application of a novel liquid chromatography tandem mass spectrometry assay measuring uracil, 5, 6-dihydrouracil, 5-fluorouracil, 5, 6-dihydro-5 … O Chavani, BP Jensen, RM Strother, CM Florkowski, PM George Journal of pharmaceutical and biomedical analysis 142, 125-135, 2017 | 33 | 2017 |
| Task shifting and skin punch for the histologic diagnosis of Kaposi's sarcoma in sub-Saharan Africa: A public health solution to a public health problem MO Laker-Oketta, M Wenger, A Semeere, B Castelnuovo, A Kambugu, ... Oncology 89 (1), 60-65, 2015 | 33 | 2015 |
| Pegylated liposomal doxorubicin in ovarian cancer R Strother, D Matei Therapeutics and Clinical Risk Management, 639-650, 2009 | 33 | 2009 |
| Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation N Vélez de Mendizábal, RM Strother, SS Farag, HE Broxmeyer, ... Clinical pharmacokinetics 53, 247-259, 2014 | 31 | 2014 |
| Intralesional SD-101 in combination with pembrolizumab in anti-PD-1 treatment-naïve head and neck squamous cell carcinoma: results from a multicenter, phase II trial EEW Cohen, L Nabell, DJ Wong, T Day, GA Daniels, M Milhem, S Deva, ... Clinical Cancer Research 28 (6), 1157-1166, 2022 | 30 | 2022 |
| Phase 1b/2, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and … EEW Cohen, L Nabell, DJL Wong, TA Day, GA Daniels, MM Milhem, ... Journal of Clinical Oncology 37 (15_suppl), 6039-6039, 2019 | 30 | 2019 |
